Diet Pills Take Over: Weight Watchers' Downfall in the Age of Pharmaceutical Weight Loss
- by Lutz Meier
- 2 Min
Weight Loss Injections Overtake Diet Sector Amidst Weight Watchers Bankruptcy - Diet Business Dominance: Weight Watchers Urgently Endorses Weight Loss Injections as Game-Changers
The bankruptcy announced by legendary diet firm Weight Watchers heralds a total flip in the weight loss industry. Founded six decades ago in NYC, the company filed for Chapter 11 protection last week to cast off billions in debt under US law. Despite the filing, the company assures that its business operations will proceed.
However, a closer look at the company's finances paints a grim picture. Revenue has halved since 2018, down to a mere $786 million. Weight Watchers gained popularity by selling the self-help group concept at a premium – overweight individuals paid for weekly gatherings with like-minded folks, while a meal-point system promoted dietary changes. Complementary products, including special diet foods and licensing deals, brought in extra money.
But in recent years, consumers no longer gravitated towards weekly meetings and rigid diet controls. Social attitudes towards body image have evolved significantly, forcing Weight Watchers to innovate with weight loss apps, fitness trackers, and telemedicine offerings. Yet, these attempts were merely drops in the ocean against the rising tide of competition.
The COVID-19 pandemic has been instrumental in accelerating the company's downfall. Weight Watchers shed a considerable number of coaches during the pandemic, and the move away from in-person gatherings gained momentum.
Oprah's Exit from Weight Watchers to Diet Shots
Former Weight Watchers spokesperson, media mogul Oprah Winfrey, could not turn around the company's fortunes. In 2015, she became an investor, holding 10% of the company's shares and joining the board of directors. In 2024, she parted ways with the company, selling heavily devalued shares and charitably donating the proceeds. Winfrey later admitted to trusting weight loss injections over traditional methods.
The rise of these medications over the past couple of years is one key factor contributing to Weight Watchers' struggle. Pills from companies like Novo Nordisk (Denmark) and Eli Lilly (US), including Ozempic, Wegovy, and Zepbound, are drastically altering the weight loss framework. Their popularity has soared across the US and numerous other countries, as people opt for these injections over permanent dietary changes. These medications have even propelled the creators to new heights – at one point, Novo Nordisk was the most valuable European company on the stock market.
Manufacturing output is currently driving the increase in these medications, as manufacturers have finally increased production to meet record demand. In the near future, the game-changer may be a pill version of the active ingredient, eliminating the need for injections altogether. Eli Lilly plans to release pill versions in the next year following successful clinical trials.
By partnering with stern, Capital delivers top-tier content, some of which can be accessed exclusively with a stern subscription. More insights can be found at www.stern.de/capital.
- Weight Watchers
- Pharmaceutical Industry
- Weight Loss Medications
- Novo Nordisk
- The rise of weight loss medications, such as those produced by Novo Nordisk and Eli Lilly, has significantly impacted the weight loss industry, reducing the need for traditional self-help programs like Weight Watchers' community-based approach.
- Science, health-and-wellness, therapies-and-treatments, and employment policy are key areas where the pharmaceutical industry, including companies like Novo Nordisk, invest heavily to research, develop, and implement weight loss medications, contributing to the industry's growth and the changes in the marketplace.
